skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection

Expert Opinion

(2100) Views  (594) Full article downloads

Authors: Christine Katlama, Robert Murphy

Published Date April 2009 Volume 2009:5 Pages 331 - 340
DOI: http://dx.doi.org/10.2147/TCRM.S3137

Christine Katlama, Robert Murphy

Pierre et Marie Curie Université – Paris 6, Service de Maladies Infectieuses et Tropicales, Paris, France

Abstract: Integrase is an essential HIV-1-specific enzyme that is an active target for antiretroviral drug development. Recently, a new class of drugs that specifically inhibits strand transfer, one of the three steps of HIV integration into the host DNA, has been developed. Two drugs in this class have reached late stages of development for use in HIV-1 infected individuals: raltegravir, which has just been approved for use in treatment-experienced patients, and elvitegravir, currently in phase III trials. Both are potent with an IC50 in the 30 nM range and active in vitro against wild type as well as in strains highly resistant to all other existing classes of drugs. Clinical trials in both treatment-naïve and -experienced patients have demonstrated raltegravir to be highly effective with an excellent tolerability profile and no specific clinical or metabolic side effects. Longer follow up is necessary to ensure this early safety profile is sustained. The rapid rate of viral decay observed with raltegravir challenges the current understanding of HIV-1 turnover and may open new strategies for long term treatment and management of infected patients.

Keywords: integrase inhibitors, antiretroviral therapy, treatment failure, raltegravir, elvitegravir








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Comparison of linear–stochastic and nonlinear–deterministic algorithms in the analysis of 15-minute clinical ECGs to predict risk of arrhythmic death
Health literacy and health seeking behavior among older men in a middle-income nation
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Erratum
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
Zinc oxide nanoparticles as selective killers of proliferating cells
Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasis
Erratum
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy